The low-affinity neurotrophin receptor, p75, is upregulated in ganglioneuroblastoma/ganglioneuroma and reduces tumorigenicity of neuroblastoma cells in vivo
Article first published online: 4 DEC 2008
Copyright © 2009 Wiley-Liss, Inc.
International Journal of Cancer
Volume 124, Issue 10, pages 2488–2494, 15 May 2009
How to Cite
Schulte, J. H., Pentek, F., Hartmann, W., Schramm, A., Friedrichs, N., Øra, I., Koster, J., Versteeg, R., Kirfel, J., Buettner, R. and Eggert, A. (2009), The low-affinity neurotrophin receptor, p75, is upregulated in ganglioneuroblastoma/ganglioneuroma and reduces tumorigenicity of neuroblastoma cells in vivo. Int. J. Cancer, 124: 2488–2494. doi: 10.1002/ijc.24204
- Issue published online: 16 MAR 2009
- Article first published online: 4 DEC 2008
- Accepted manuscript online: 4 DEC 2008 12:00AM EST
- Manuscript Accepted: 28 OCT 2008
- Manuscript Received: 15 JUN 2008
- National Genome Research Network (NGFN)
- EU (Framework 6, EET Pipeline)
- Swedish Childhood Cancer Foundation, DFG
Additional Supporting Information may be found in the online version of this article.
|IJC_24204_sm_Supptable1.tif||80K||Supplemental Tab1: Summary of the results of p75 analysis on the TMA.|
|IJC_24204_sm_Supptable2.tif||72K||Supplemental Tab2: Results of Kruskal-Wallis analysis of p75 protein expression in 93 neuroblastic tumours.|
|IJC_24204_sm_Suppfig1.tif||95K||Supplemental Figure 1|
|IJC_24204_sm_Suppfig2A.tif||141K||Supplemental Figure 2A|
|IJC_24204_sm_Suppfig2B.tif||142K||Supplemental Figure 2B|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.